Search results

This guideline covers identifying and managing adrenal insufficiency (hypoadrenalism) in babies, children, young people and adults. It aims to improve the treatment of primary, secondary and tertiary adrenal insufficiency, and the prevention and management of adrenal crisis.

Result type

NICE guideline

Published

28 August 2024

Evidence-based recommendations on genicular artery embolisation for pain from knee osteoarthritis. This involves inserting a tube through an artery in the groin into the genicular artery, and injecting tiny particles through it to block new blood vessels.

Result type

HealthTech guidance

Published

27 October 2021

Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Result type

HealthTech guidance

Published

24 June 2020

Evidence-based recommendations on minimally invasive video-assisted parathyroidectomy. This involves inserting surgical instruments through a small cut (keyhole surgery) to find and remove any abnormal glands.

Result type

HealthTech guidance

Published

23 August 2014

NICE is unable to recommend the use in the NHS of tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia. This is because Lilly did not provide an evidence submission

Result type

Technology appraisal guidance

Published

23 January 2013

NICE has developed a medtech innovation briefing (MIB) on the VEST external stent for coronary artery bypass grafts .

Result type

Medtech innovation briefing

Published

2 August 2017

Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia.

Result type

HealthTech guidance

Published

29 November 2022

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves positioning a temporary implant in the urethra to increase the flow of urine.

Result type

HealthTech guidance

Published

21 September 2022

Evidence-based recommendations on image-guided radiofrequency excision biopsy of breast lesions. This involves inserting a probe that uses radiofrequency energy to cut through the breast internally, and removing the lump with a small area of surrounding tissue to test for cancer.

Result type

HealthTech guidance

Published

22 July 2009

Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves blocking the blood vessels supplying the prostate with tiny plastic particles.

Result type

HealthTech guidance

Published

25 April 2018

Evidence-based recommendations on insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. This involves pulling back the parts of the prostate that are pressing on the urethra so that it's no longer blocked.

Result type

HealthTech guidance

Published

23 January 2014

Evidence-based recommendations on transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia. This involves using laser energy to destroy some of the prostate tissue.

Result type

HealthTech guidance

Published

8 January 2025

Evidence-based recommendations on transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves injecting a high-speed jet of water into the prostate to destroy some of the prostate tissue and widen the urethra.

Result type

HealthTech guidance

Published

14 September 2023

Awaiting development Reference number: GID-MT599 Expected publication date: TBC

Result type

Medical technologies guidance

Status

Awaiting development

Evidence-based recommendations on transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves using heated water vapour to destroy some of the prostate tissue.

Result type

HealthTech guidance

Published

21 August 2018